Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2025
2025-05-23 08:25
Emergers publishes updated analysis about Prolight Diagnostics
2025-05-21 18:45
NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
Regulatory
2025-05-21 18:25
Prolight has resolved on a rights issue of shares to complete the development of the Point of Care system Psyros™ and reach commercialisation
Regulatory
MAR
2025-05-09 08:00
Prolight receives new MicroFlex patent approval in the US
2025-04-28 08:00
Prolight secures first two European patents for Psyros™ technology
2025-04-23 10:45
Study highlights speed of biomarker integration on Psyros POC platform
2025-03-31 08:00
Prolight announces positive pre-clinical data
Regulatory
MAR
2025-03-26 08:00
Prolight receives notice of allowance for MicroFlex patent
2025-03-13 08:00
The Psyros™ Cartridge Pilot Manufacturing line achieves another milestone!
2025-02-28 09:50
Prolight Diagnostics publishes year-end report 2024
Regulatory
MAR
Previous
Next
